WIPO Defends Involvement In IP Enforcement Meeting In The Philippines

The World Intellectual Property Organization, a United Nations agency with nearly 200 member states, is under criticism for its connection with a Western industry-heavy event this week in the Philippines aimed at fighting intellectual property counterfeiting and piracy. The concern from technology industry and consumer advocates is that WIPO is involved in an overly one-sided event and did not sufficiently notify its diverse membership or the public of its activities.

WTO IP Committee Addresses Medicines Access, Plain-Packaged Tobacco, ACTA

The World Trade Organization committee responsible for intellectual property rights issues is meeting this week and will address several items of potential debate, including a nearly unused 2003 provision for compulsory-licensed medicines exports to poor countries, a WTO member’s attempt to discourage smoking through unlabelled tobacco packaging, and IP enforcement raised by a small but potent group of WTO members who negotiated the Anti-Counterfeiting Trade Agreement (ACTA).

Palestinian Membership In UNESCO Could Raise Questions For US At WIPO

Members of the Paris-based United Nations Educational, Scientific and Cultural Organisation (UNESCO) are preparing to vote to allow Palestine to become a member, according to sources. If this happens, it could create uncertainty about United States membership in UN agencies, including the World Intellectual Property Organization.

How To Respond To A Cease & Desist Letter

US companies are generally known to be much more litigious than non-US companies. Thus, if you are a non-US company looking to enter the US market, it is prudent to understand the nuances of responding to a cease and desist letter. While cease and desist letters can be upsetting and sometimes confusing, there are a series of steps that companies can take to be better prepared in the event that they do receive one.

UPOV Sprouts A New Public Face – As Farmers Protest

On the occasion of its 50th anniversary, the International Union for the Protection of New Varieties of Plants (UPOV) is trying to dispel its image as a non-transparent organisation and is working on a new user-friendly website with public access to a number of formerly reserved documents. Meanwhile, for the first time farmers protested outside the UPOV building in Geneva, as they seek to preserve the ancient practice of saving seeds from their harvests to use the next year.

UPOV Marks 50 Years; Breeders Seek More Enforcement, Civil Society Wants In

This week the International Union for the Protection of New Varieties of Plants (UPOV) is celebrating its 50th anniversary. The Union is often criticised by civil society as being opaque, but plant breeders seem reasonably content with the latest version of the convention. However, some breeders that do not rely on seeds to reproduce their plants are seeking a clarification in the convention to prevent illegal use of their protected varieties.

Copyright Infrastructure In The Digital Age: Raising Awareness At WIPO

A global meeting entitled “Enabling Creativity in the Digital Environment: Copyright Documentation and Infrastructure” was held at the World Intellectual Property Organization 13-14 October. Gathering representatives of governments, business leaders, academics, and other stakeholders, the conference was organised in the framework of the Development Agenda Thematic Project on Intellectual Property and the Public Domain.

WIPO To Launch New Drug R&D Database For Neglected Disease Licences

The World Intellectual Property Organization, in conjunction with the World Health Organization, private sector and foundation partners, is preparing to launch a new voluntary database for the sharing of intellectual property for research and development on medicines, vaccines and diagnostics for neglected diseases, according to sources in Geneva.

EU High Court Bans Patents On Human Embryo Stem Cells For Commerce

The European Union high court today outlawed the patenting of human embryo stem cells for scientific research or commercial purposes. The decision has forced European courts to examine the “ethical boundaries of patenting,” said Greenpeace, which challenged a German patent in the case. While there are alternate methods for obtaining stem cells, the ruling will nevertheless affect some research, one patent lawyer said.